Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Laposata

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
American Journal of Clinical Pathology|April 25, 2003
The timing of a positive test result for heparin-induced thrombocytopenia relative to the platelet count and anticoagulant therapy in 43 consecutive casesMajed A Refaai, Elizabeth M Van Cott, Michael Laposata
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 19, 2004
Prothrombin gene mutation G20210A, homocysteine, antiphospholipid antibodies and other hypercoagulable states in ocular thrombosisElizabeth M Van Cott, Michael Laposata, M Elizabeth Hartnett
Archives of Pathology & Laboratory Medicine|April 18, 2002
Activated protein C resistance, the factor V Leiden mutation, and a laboratory testing algorithmElizabeth M Van Cott, Britt L Soderberg, Michael Laposata
Archives of Pathology & Laboratory Medicine|November 8, 2002
Laboratory evaluation of hypercoagulability with venous or arterial thrombosisElizabeth M Van Cott, Michael Laposata, Martin H Prins
Clinics in Laboratory Medicine|July 24, 2002
Hypercoagulability test strategies in the protein C and protein S pathwayElizabeth M Van Cott, Britt L Soderberg, Michael Laposata
Biochimica Et Biophysica Acta|December 6, 2005
Fatty acid ethyl esters, nonoxidative ethanol metabolites, synthesis, uptake, and hydrolysis by human plateletsRaneem O Salem, Joanne E Cluette-Brown, Michael Laposata
American Journal of Clinical Pathology|January 11, 2003
Clinical significance of a borderline titer in a negative ELISA test for heparin-induced thrombocytopeniaMajed A Refaai, Michael Laposata, Elizabeth M Van Cott
Prostaglandins, Leukotrienes, and Essential Fatty Acids|November 27, 2007
Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosisM Rabie Al-Turkmani, Steven D Freedman, Michael Laposata
The New England Journal of Medicine|January 12, 2007
Case records of the Massachusetts General Hospital. Case 1-2007. A 40-year-old woman with epistaxis, hematemesis, and altered mental statusMichael Laposata, Elizabeth M Van Cott, Michael H Lev
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 31, 2005
Comparison of serum fatty acid ethyl esters and urinary 5-hydroxytryptophol as biochemical markers of recent ethanol consumptionAdam Bisaga, Michael Laposata, Shan Xie, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
American Journal of Clinical Pathology|April 25, 2003
The timing of a positive test result for heparin-induced thrombocytopenia relative to the platelet count and anticoagulant therapy in 43 consecutive casesMajed A Refaai, Elizabeth M Van Cott, Michael Laposata
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 19, 2004
Prothrombin gene mutation G20210A, homocysteine, antiphospholipid antibodies and other hypercoagulable states in ocular thrombosisElizabeth M Van Cott, Michael Laposata, M Elizabeth Hartnett
Archives of Pathology & Laboratory Medicine|April 18, 2002
Activated protein C resistance, the factor V Leiden mutation, and a laboratory testing algorithmElizabeth M Van Cott, Britt L Soderberg, Michael Laposata
Archives of Pathology & Laboratory Medicine|November 8, 2002
Laboratory evaluation of hypercoagulability with venous or arterial thrombosisElizabeth M Van Cott, Michael Laposata, Martin H Prins
Clinics in Laboratory Medicine|July 24, 2002
Hypercoagulability test strategies in the protein C and protein S pathwayElizabeth M Van Cott, Britt L Soderberg, Michael Laposata
Biochimica Et Biophysica Acta|December 6, 2005
Fatty acid ethyl esters, nonoxidative ethanol metabolites, synthesis, uptake, and hydrolysis by human plateletsRaneem O Salem, Joanne E Cluette-Brown, Michael Laposata
American Journal of Clinical Pathology|January 11, 2003
Clinical significance of a borderline titer in a negative ELISA test for heparin-induced thrombocytopeniaMajed A Refaai, Michael Laposata, Elizabeth M Van Cott
Prostaglandins, Leukotrienes, and Essential Fatty Acids|November 27, 2007
Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosisM Rabie Al-Turkmani, Steven D Freedman, Michael Laposata
The New England Journal of Medicine|January 12, 2007
Case records of the Massachusetts General Hospital. Case 1-2007. A 40-year-old woman with epistaxis, hematemesis, and altered mental statusMichael Laposata, Elizabeth M Van Cott, Michael H Lev
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 31, 2005
Comparison of serum fatty acid ethyl esters and urinary 5-hydroxytryptophol as biochemical markers of recent ethanol consumptionAdam Bisaga, Michael Laposata, Shan Xie, et al.
Pageof 11